K. Poh

发表

Efficacy and Safety of Inclisiran in Asian Patients

Anastasia Lesogor, Chern-En Chiang, Yong Huo, 2023, JACC. Asia.

Left ventricular remodelling patterns in patients with moderate aortic stenosis

N. Marsan, S. Ewe, S. Butcher, 2022, European heart journal. Cardiovascular Imaging.

Multimodal Cardiac Imaging in the Assessment of Patients Who Have Suffered a Cardioembolic Stroke: A Review

C. Sia, W. Kong, K. Poh, 2023, Journal of cardiovascular development and disease.

Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention.

K. Poh, H. Tan, P. Chai, 2009, Singapore medical journal.

Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

J. Spertus, H. Suryapranata, A. Bagai, 2024, Journal of the American Heart Association.

Healthcare and environmental sustainability

T. Ang, K. Poh, Mahesh Choolani, 2024, Singapore medical journal.

Atherosclerotic cardiovascular disease landscape in Singapore

P. Loh, K. Poh, C. Sia, 2024, Frontiers in cardiovascular medicine.

Ischaemia with no obstructive coronary arteries: a review with focus on the Asian population

P. Loh, T. Yeo, W. Kong, 2024, Singapore medical journal.

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

H. Huikuri, H. Suryapranata, A. Bagai, 2024, European heart journal. Cardiovascular pharmacotherapy.

Heart failure risk assessment in patients with hypertrophic cardiomyopathy based on the H2FPEF score.

V. Kamperidis, N. Ajmone Marsan, T. Zegkos, 2024, European journal of heart failure.

Increased left ventricular remodelling index in paradoxical low-flow severe aortic stenosis with preserved left ventricular ejection fraction compared to normal-flow severe aortic stenosis.

T. Yeo, J. N. Ngiam, I. Kuntjoro, 2024, Singapore medical journal.